哈三联2025年净利预亏3.15亿元至3.75亿元

Core Viewpoint - The company Hasi Lian (002900) is expected to report a significant loss in 2025, with a projected net profit attributable to shareholders ranging from -315 million to -375 million yuan, indicating a shift from profit to loss year-on-year [2] Financial Performance - The company's anticipated total revenue for 2025 is approximately 790 million yuan, reflecting a year-on-year decrease of 343 million yuan, or 30% [2] - The decline in revenue is attributed to the impact of national drug procurement policies and intense competition in the market for certain non-procurement products [2] Cost and Profitability - The gross profit, calculated as revenue minus operating costs, is insufficient to cover sales, management, and research and development expenses, leading to a challenging financial situation for the company [2] - The direct cause of the performance decline is identified as a significant drop in sales prices [2]